Vasculogenic mimicry and its clinical significance in medulloblastoma

Cancer Biology and Therapy

Volumn 13, Issue 5, 2012, Pages 341-348

  Wang, Shi Yong ^a   Yu, Li ^a   Ling, Geng Qiang ^a   Xiao, Sha ^a   Sun, Xin Lin ^a   Song, Zhen Hua ^a   Liu, Yi Jing ^a   Jiang, Xiao Dan ^a   Cai, Ying Qian ^a   Ke, Yi Quan ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Medulloblastoma; Microvessel density; Prognosis; Vasculogenic mimicry

Indexed keywords

EPHRIN RECEPTOR A2; GELATINASE A; LAMININ 5GAMMA2; MATRIX METALLOPROTEINASE 14; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CANCER TISSUE; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDULLOBLASTOMA; MICROVASCULATURE; OVERALL SURVIVAL; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; SCHOOL CHILD; SURVIVAL TIME; TUMOR VASCULARIZATION; VASCULOGENIC MIMICRY;

EID: 84863244760     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.19108     Document Type: Article

References (32)

1. Ellison DW. Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease. Acta Neuropathol 2010; 120:305-16; PMID:20652577; http://dx.doi.org/10.1007/s00401-010-0726-6.
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1:27-31; PMID:7584949; http://dx.doi.org/10.1038/nm0195- 27.
3. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'Er J, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999; 155:739-52; PMID:10487832; http://dx.doi.org/10.1016/S0002-9440(10)65173-5.
4. Shih IM. Trophoblastic vasculogenic mimicry in gestational choriocarcinoma. Mod Pathol 2011; 24:646-52; PMID:21217646; http://dx.doi.org/ 10.1038/modpathol.2010.231.
5. El HS, Boisselier B, Peglion F, Rousseau A, Colin C, Idbaih A, et al. A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry. Brain 2010; 133:973-82; PMID:20375132; http://dx.doi.org/10.1093/brain/ awq044.
6. van der Schaft DW, Hillen F, Pauwels P, Kirschmann DA, Castermans K, Egbrink MG, et al. Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia. Cancer Res 2005; 65:11520-8; PMID:16357161; http://dx.doi.org/10.1158/0008-5472.CAN-05-2468.
7. Yue WY, Chen ZP. Does vasculogenic mimicry exist in astrocytoma? J Histochem Cytochem 2005; 53:997-1002; PMID:15923371; http://dx.doi.org/10.1369/ jhc.4A6521.2005.
8. Shirakawa K, Wakasugi H, Heike Y, Watanabe I, Yamada S, Saito K, et al. Vasculogenic mimicry and pseudo-comedo formation in breast cancer. Int J Cancer 2002; 99:821-8; PMID:12115483; http://dx.doi.org/10.1002/ijc.10423.
9. Liu XM, Zhang QP, Mu YG, Zhang XH, Sai K, Pang JC, et al. Clinical significance of vasculogenic mimicry in human gliomas. J Neurooncol 2011; In press; PMID:21533525; http://dx.doi.org/10.1007/s11060-011-0578-5.
10. Vartanian AA, Stepanova EV, Gutorov SL, Solomko E, Grigorieva IN, Sokolova IN, et al. Prognostic significance of periodic acid-Schiff-positive patterns in clear cell renal cell carcinoma. Can J Urol 2009; 16:4726-32; PMID:19671223.
11. Sun B, Qie S, Zhang S, Sun T, Zhao X, Gao S, et al. Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors. Hum Pathol 2008; 39:444-51; PMID:18261629; http://dx.doi.org/10.1016/j.humpath.2007.07.018.
12. Sun B, Zhang S, Zhao X, Zhang W, Hao X. Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas. Int J Oncol 2004; 25:1609-14; PMID:15547697.
13. Sood AK, Fletcher MS, Zahn CM, Gruman LM, Coffin JE, Seftor EA, et al. The clinical significance of tumor cell-lined vasculature in ovarian carcinoma: implications for anti-vasculogenic therapy. Cancer Biol Ther 2002; 1:661-4; PMID:12642690.
14. van der Schaft DW, Seftor RE, Seftor EA, Hess AR, Gruman LM, Kirschmann DA, et al. Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells. J Natl Cancer Inst 2004; 96:1473-7; PMID:15467037; http://dx.doi. org/10.1093/jnci/djh267.
15. Grizzi F, Weber C, Di Ieva A. Anti-angiogenic strategies in medulloblastoma: reality or mystery? Pediatr Res 2008; In press.
16. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003; 9:702-12; PMID:12778169; http://dx.doi.org/10.1038/nm0603-702.
17. Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer 2003; 3:411-21; PMID:12778131; http://dx.doi.org/10.1038/nrc1092.
18. Hendrix MJ, Seftor EA, Kirschmann DA, Seftor RE. Molecular biology of breast cancer metastasis. Molecular expression of vascular markers by aggressive breast cancer cells. Breast Cancer Res 2000; 2:417-22; PMID:11250735; http://dx.doi.org/10.1186/bcr88.
19. Sood AK, Seftor EA, Fletcher MS, Gardner LM, Heidger PM, Buller RE, et al. Molecular determinants of ovarian cancer plasticity. Am J Pathol 2001; 158:1279-88; PMID:11290546; http://dx.doi.org/10.1016/S0002-9440(10)64079-5.
20. Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T, et al. Tumour vascularization via endothelial differentiation of glioblastoma stemlike cells. Nature 2010; 468:824-8; PMID:21102434; http://dx.doi.org/10. 1038/nature09557.
21. Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga KE, Geber A, et al. Glioblastoma stemlike cells give rise to tumour endothelium. Nature 2010; 468:829-33; PMID:21102433; http://dx.doi.org/10.1038/nature09624.
22. Yao XH, Ping YF, Bian XW. Contribution of cancer stem cells to tumor vasculogenic mimicry. Protein Cell 2011; 2:266-72; PMID:21533771; http://dx.doi.org/10.1007/s13238-011-1041-2.
23. Folberg R, Maniotis A. Vasculogenic mimicry. APMIS 2004; 112:508-25; PMID:15563313; http://dx.doi.org/10.1111/j.1600-0463.2004.apm11207-0810.x.
24. Clarijs R, Otte-Holler I, Ruiter DJ, de Waal RM. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma. Invest Ophthalmol Vis Sci 2002; 43:912-8; PMID:11923228.
25. Frenkel S, Barzel I, Levy J, Lin AY, Bartsch DU, Majumdar D, et al. Demonstrating circulation in vasculogenic mimicry patterns of uveal melanoma by confocal indocyanine green angiography. Eye (Lond) 2008; 22:948-52; PMID:17363922; http://dx.doi.org/10.1038/sj.eye.6702783.
26. Hess AR, Seftor EA, Seftor RE, Hendrix MJ. Phosphoinositide-3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Res 2003; 63:4757-62; PMID:12941789.
27. Seftor RE, Seftor EA, Koshikawa N, Meltzer PS, Gardner LM, Bilban M, et al. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase- 2 and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res 2001; 61:6322-7; PMID:11522618.
28. Vartanian A, Stepanova E, Grigorieva I, Solomko E, Baryshnikov A, Lichinitser M. VEGFR1 and PKCalpha signaling control melanoma vasculogenic mimicry in a VEGFR2 kinase-independent manner. Melanoma Res 2011; 21:91-8; PMID:21389833; http://dx.doi. org/10.1097/CMR.0b013e328343a237.
29. Tural S, Gercek A, Konya D, Ozgen S, Toplamoglu H, Ozek MM. Microvessel density and vascular endothelial growth factor expression as predictors of childrens'survival from cerebellar medulloblastoma. J Clin Neurosci 2009; 16:1199-202; PMID:19524442; http://dx.doi.org/10.1016/j.jocn.2008.10.026.
30. Seftor EA, Meltzer PS, Schatteman GC, Gruman LM, Hess AR, Kirschmann DA, et al. Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry. Crit Rev Oncol Hematol 2002; 44:17-27; PMID:12398997; http:// dx.doi.org/10.1016/S1040-8428(01)00199-8.
31. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114:97-109; PMID:17618441; http://dx.doi.org/10.1007/s00401- 007-0243-4.
32. Foote RL, Weidner N, Harris J, Hammond E, Lewis JE, Vuong T, et al. Evaluation of tumor angiogenesis measured with microvessel density (MVD) as a prognostic indicator in nasopharyngeal carcinoma: results of RTOG 9505. Int J Radiat Oncol Biol Phys 2005; 61:745-53; PMID:15708253; http://dx.doi.org/10. 1016/j.ijrobp.2004.07.694.